The virus employs type II latency, expressing proteins such as EBNA-1, LMP-1, and LMP-2, which promote tumorigenesis and create an immunosuppressive tumor microenvironment (TME) through cytokine induction and PD-L1 upregulation (Figure 2). This evidence concerns the gene PDLIM7 and neoplasm.